本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盤後16.910.00000.00%16:02 EDT
成交量:142.66萬
成交額:2,406.49萬
市值:17.78億
市盈率:-11.68
高:17.30
開:16.64
低:16.05
收:16.68
資料載入中...
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/06/29

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/17

重要事件披露

Form 8-K - Current report